Market Cap : 1.5 B | Enterprise Value : 1.04 B | PE Ratio : At Loss | PB Ratio : 3.54 |
---|
NAS:CLOV has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:CLOV has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
As of today (2022-08-18), Clover Health Investments's weighted average cost of capital is 9.47%. Clover Health Investments's ROIC % is -47.05% (calculated using TTM income statement data). Clover Health Investments earns returns that do not match up to its cost of capital. It will destroy value as it grows.
*Note: The beta of this company cannot be obtained because it has a price history shorter than 3 years. It will thus be set to 1 as default to calculate WACC.
The historical data trend for Clover Health Investments's WACC % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Clover Health Investments's WACC %, along with its competitors' market caps and WACC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's WACC % distribution charts can be found below:
* The bar in red indicates where Clover Health Investments's WACC % falls into.
The weighted average cost of capital (WACC) is the rate that a company is expected to pay on average to all its security holders to finance its assets. The WACC is commonly referred to as the firm's cost of capital. Generally speaking, a company's assets are financed by debt and equity. WACC is the average of the costs of these sources of financing, each of which is weighted by its respective use in the given situation. By taking a weighted average, we can see how much interest the company has to pay for every dollar it finances.
WACC | = | E | / | (E + D) | * | Cost of Equity | + | D | / | (E + D) | * | Cost of Debt | * | (1 - Tax Rate) |
1. Weights:
Generally speaking, a company's assets are financed by debt and equity. We need to calculate the weight of equity and the weight of debt.
The market value of equity (E) is also called "Market Cap". As of today, Clover Health Investments's market capitalization (E) is $1502.187 Mil.
The market value of debt is typically difficult to calculate, therefore, GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding the latest two-year average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together. As of Jun. 2022, Clover Health Investments's latest two-year average Short-Term Debt & Capital Lease Obligation was $14.3285 Mil and its latest two-year average Long-Term Debt & Capital Lease Obligation was $68.765 Mil. The total Book Value of Debt (D) is $83.0935 Mil.
a) weight of equity = E / (E + D) = 1502.187 / (1502.187 + 83.0935) = 0.9476
b) weight of debt = D / (E + D) = 83.0935 / (1502.187 + 83.0935) = 0.0524
2. Cost of Equity:
GuruFocus uses Capital Asset Pricing Model (CAPM) to calculate the required rate of return. The formula is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)
a) GuruFocus uses 10-Year Treasury Constant Maturity Rate as the risk-free rate. It is updated daily. The current risk-free rate is 2.87100000%. Please go to Economic Indicators page for more information. Please note that we use the 10-Year Treasury Constant Maturity Rate of the country/region where the company is headquartered. If the data for that country/region is not available, then we will use the 10-Year Treasury Constant Maturity Rate of the United States as default.
b) Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. Clover Health Investments's beta cannot be obtained because it has a price history shorter than 3 years. It will thus be set to 1 as default to calculate WACC.
c) (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
Cost of Equity = 2.87100000% + 1 * 6% = 8.871%
3. Cost of Debt:
GuruFocus uses last fiscal year end Interest Expense divided by the latest two-year average debt to get the simplified cost of debt.
As of Dec. 2021, Clover Health Investments's interest expense (positive number) was $16.91 Mil. Its total Book Value of Debt (D) is $83.0935 Mil.
Cost of Debt = 16.91 / 83.0935 = 20.3506%.
4. Multiply by one minus Average Tax Rate:
GuruFocus uses the latest two-year average tax rate to do the calculation. The calculated average tax rate is limited to between 0% and 100%. If the calculated average tax rate is higher than 100%, it is set to 100%. If the calculated average tax rate is less than 0%, it is set to 0%.
The latest Two-year Average Tax Rate is 0%.
Clover Health Investments's Weighted Average Cost Of Capital (WACC) for Today is calculated as:
WACC | = | E / (E + D) | * | Cost of Equity | + | D / (E + D) | * | Cost of Debt | * | (1 - Tax Rate) |
= | 0.9476 | * | 8.871% | + | 0.0524 | * | 20.3506% | * | (1 - 0%) | |
= | 9.47% |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Because it costs money to raise capital. A firm that generates higher ROIC % than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.
As of today, Clover Health Investments's weighted average cost of capital is 9.47%. Clover Health Investments's ROIC % is -47.05% (calculated using TTM income statement data). Clover Health Investments earns returns that do not match up to its cost of capital. It will destroy value as it grows.
*Note: The beta of this company cannot be obtained because it has a price history shorter than 3 years. It will thus be set to 1 as default to calculate WACC.
1. GuruFocus uses book value of debt (D) to do the calculation. It is simplified by adding latest two-year average Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation together.
2. The WACC formula discussed above does not include Preferred Stock. Please adjust if preferred stock is considered.
3. (Expected Return of the Market - Risk-Free Rate of Return) is also called market premium. GuruFocus requires market premium to be 6%.
4. GuruFocus uses last fiscal year end Interest Expense divided by the latest two-year average debt to get the simplified cost of debt.
Sharp Aric R | officer: CEO of Value Based Care | C/O CLOVER HEALTH INVESTMENTS, CORP. 3401 MALLORY LANE, SUITE 210 FRANKLIN TN 37067 |
Martin Joseph Richards | officer: General Counsel | C/O LOUISIANA-PACIFIC CORPORATION 414 UNION STREET, SUITE 2000 NASHVILLE TN 37219 |
Herbers Mark | officer: Interim CFO | 500 CUMMINGS CENTER SUITE 6550 BEVERLY MA 01915 |
Wagner Joseph F. | officer: Chief Financial Officer | C/O CLOVER HEALTH INVESTMENTS, CORP. 725 COOL SPRINGS BLVD., SUITE 320 FRANKLIN TN 37067 |
Reynoso Jamie L. | officer: Chief Operating Officer | C/O CLOVER HEALTH INVESTMENTS, CORP. 725 COOL SPRINGS BLVD., SUITE 320 FRANKLIN TN 37067 |
Singh Prabhdeep | officer: Chief Growth Officer | C/O CLOVER HEALTH INVESTMENTS, CORP. 725 COOL SPRINGS BLVD., SUITE 320 FRANKLIN TN 37067 |
Kouzoukas Demetrios L. | director | C/O CLOVER HEALTH INVESTMENTS, CORP. 725 COOL SPRINGS BLVD., SUITE 320 FRANKLIN FL 37067 |
Robinson William G Jr | director | 3150 SABRE DRIVE SOUTHLAKE TX 76092 |
Mehta Neil | 10 percent owner | 535 PACIFIC AVENUE 4TH FLOOR SAN FRANCISCO CA 94133 |
Clinton Chelsea | director | C/O IAC 555 W 18TH STREET NEW YORK NY 10011 |
Greenoaks Capital Partners Llc | 10 percent owner | 535 PACIFIC AVENUE 4TH FLOOR SAN FRANCISCO CA 94133 |
Peretz Benjamin | 10 percent owner | 535 PACIFIC AVENUE 4TH FLOOR SAN FRANCISCO CA 94133 |
Garipalli Vivek | director, 10 percent owner, officer: Chief Executive Officer | C/O CLOVER HEALTH INVESTMENTS, CORP. 725 COOL SPRINGS BLVD., SUITE 320 FRANKLIN TN 37067 |
Lee Gia | officer: General Counsel & Secretary | C/O CLOVER HEALTH INVESTMENTS, CORP. 725 COOL SPRINGS BLVD., SUITE 320 FRANKLIN TN 37067 |
Turner Nathaniel S. | director | C/O CLOVER HEALTH INVESTMENTS, CORP. 725 COOL SPRINGS BLVD., SUITE 320 FRANKLIN TN 37067 |
From GuruFocus
Other Sources
By Zacks 2021-12-22
By Seekingalpha 2021-09-24
By tipranks.com 2022-02-24
By Fool 2022-01-10
By Zacks 2021-09-13
By Fool 2021-08-18
By Seekingalpha 2022-02-25
By Zacks 2022-02-14
By Fool 2021-09-07
By Zacks 2021-11-17
By Fool 2021-08-12
By Fool 2021-09-14
By Zacks 2022-02-15
By Fool 2021-11-16